 | • レポートコード：QFJ1-3919 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、血圧障害薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシン受容体遮断薬（ARB）、その他）、用途別市場規模（高血圧症、低血圧症、肺高血圧症）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・血圧障害薬の市場動向 ・企業の競争状況、市場シェア ・血圧障害薬の種類別市場規模と予測2016-2027（利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシン受容体遮断薬（ARB）、その他） ・血圧障害薬の用途別市場規模と予測2016-2027（高血圧症、低血圧症、肺高血圧症） ・血圧障害薬の北米市場規模2016-2027（アメリカ、カナダ） ・血圧障害薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・血圧障害薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・血圧障害薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・血圧障害薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（A1M Pharma AB、Acceleron Pharma Inc、Ache Laboratorios Farmaceuticos SA、Actelion Pharmaceuticals Ltd、Aerogen Ltd、Anavex Life Sciences Corp、AnGes Inc、Arena Pharmaceuticals Inc、Ascendia Pharmaceuticals LLC、Ascendis Pharma A/S、AVEO Pharmaceuticals Inc、Bayer AG、Bial - Portela & Ca SA、Bioblue Technologies Inc、Biogen Inc、Biolab Farmaceutica Ltda、BioRestorative Therapies Inc、Boryung Pharmaceutical Co Ltd、Bristol-Myers Squibb Co、Camurus AB、Capricor Therapeutics Inc、Celsion Corp、Celtaxsys Inc、Chiesi Farmaceutici SpA、Chong Kun Dang Pharmaceutical Corp、Chugai Pharmaceutical Co Ltd、CJ HealthCare Corp、Complexa Inc、Corion Biotech Srl） ・結論 |
Blood pressure disorder drug development technology and related units
High blood pressure, also known as high blood pressure, is a condition in which arterial blood pressure continues to rise. Many factors affect blood pressure, including hormone levels in the body, water and salt levels, and kidney, nervous system and blood vessels.
Most hypertensive patients do not have any signs or symptoms even if their blood pressure readings reach dangerously high levels. Although a small number of people with early-onset hypertension may experience dizziness, dizziness, or more nosebleeds than normal, these symptoms and symptoms usually do not occur until the high blood pressure reaches a critical stage. There are currently 253 products under development.
Market Analysis and Insights: Global Blood Pressure Disorders Drug Market
The global Blood Pressure Disorders Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Blood Pressure Disorders Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Blood Pressure Disorders Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Blood Pressure Disorders Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Blood Pressure Disorders Drug market.
Global Blood Pressure Disorders Drug Scope and Market Size
Blood Pressure Disorders Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Blood Pressure Disorders Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Diuretics
Angiotensin Converting Enzyme (ACE) Inhibitors
Angiotensin Receptor Blockers (ARBs)
Others
Segment by Application
Hypertension
Hypotension
Pulmonary Hypertension
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
A1M Pharma AB
Acceleron Pharma Inc
Ache Laboratorios Farmaceuticos SA
Actelion Pharmaceuticals Ltd
Aerogen Ltd
Anavex Life Sciences Corp
AnGes Inc
Arena Pharmaceuticals Inc
Ascendia Pharmaceuticals LLC
Ascendis Pharma A/S
AVEO Pharmaceuticals Inc
Bayer AG
Bial – Portela & Ca SA
Bioblue Technologies Inc
Biogen Inc
Biolab Farmaceutica Ltda
BioRestorative Therapies Inc
Boryung Pharmaceutical Co Ltd
Bristol-Myers Squibb Co
Camurus AB
Capricor Therapeutics Inc
Celsion Corp
Celtaxsys Inc
Chiesi Farmaceutici SpA
Chong Kun Dang Pharmaceutical Corp
Chugai Pharmaceutical Co Ltd
CJ HealthCare Corp
Complexa Inc
Corion Biotech Srl
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Pressure Disorders Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diuretics
1.2.3 Angiotensin Converting Enzyme (ACE) Inhibitors
1.2.4 Angiotensin Receptor Blockers (ARBs)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Blood Pressure Disorders Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hypertension
1.3.3 Hypotension
1.3.4 Pulmonary Hypertension
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Blood Pressure Disorders Drug Market Perspective (2016-2027)
2.2 Blood Pressure Disorders Drug Growth Trends by Regions
2.2.1 Blood Pressure Disorders Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Blood Pressure Disorders Drug Historic Market Share by Regions (2016-2021)
2.2.3 Blood Pressure Disorders Drug Forecasted Market Size by Regions (2022-2027)
2.3 Blood Pressure Disorders Drug Industry Dynamic
2.3.1 Blood Pressure Disorders Drug Market Trends
2.3.2 Blood Pressure Disorders Drug Market Drivers
2.3.3 Blood Pressure Disorders Drug Market Challenges
2.3.4 Blood Pressure Disorders Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Pressure Disorders Drug Players by Revenue
3.1.1 Global Top Blood Pressure Disorders Drug Players by Revenue (2016-2021)
3.1.2 Global Blood Pressure Disorders Drug Revenue Market Share by Players (2016-2021)
3.2 Global Blood Pressure Disorders Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Blood Pressure Disorders Drug Revenue
3.4 Global Blood Pressure Disorders Drug Market Concentration Ratio
3.4.1 Global Blood Pressure Disorders Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Pressure Disorders Drug Revenue in 2020
3.5 Blood Pressure Disorders Drug Key Players Head office and Area Served
3.6 Key Players Blood Pressure Disorders Drug Product Solution and Service
3.7 Date of Enter into Blood Pressure Disorders Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Pressure Disorders Drug Breakdown Data by Type
4.1 Global Blood Pressure Disorders Drug Historic Market Size by Type (2016-2021)
4.2 Global Blood Pressure Disorders Drug Forecasted Market Size by Type (2022-2027)
5 Blood Pressure Disorders Drug Breakdown Data by Application
5.1 Global Blood Pressure Disorders Drug Historic Market Size by Application (2016-2021)
5.2 Global Blood Pressure Disorders Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Blood Pressure Disorders Drug Market Size (2016-2027)
6.2 North America Blood Pressure Disorders Drug Market Size by Type
6.2.1 North America Blood Pressure Disorders Drug Market Size by Type (2016-2021)
6.2.2 North America Blood Pressure Disorders Drug Market Size by Type (2022-2027)
6.2.3 North America Blood Pressure Disorders Drug Market Size by Type (2016-2027)
6.3 North America Blood Pressure Disorders Drug Market Size by Application
6.3.1 North America Blood Pressure Disorders Drug Market Size by Application (2016-2021)
6.3.2 North America Blood Pressure Disorders Drug Market Size by Application (2022-2027)
6.3.3 North America Blood Pressure Disorders Drug Market Size by Application (2016-2027)
6.4 North America Blood Pressure Disorders Drug Market Size by Country
6.4.1 North America Blood Pressure Disorders Drug Market Size by Country (2016-2021)
6.4.2 North America Blood Pressure Disorders Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Blood Pressure Disorders Drug Market Size (2016-2027)
7.2 Europe Blood Pressure Disorders Drug Market Size by Type
7.2.1 Europe Blood Pressure Disorders Drug Market Size by Type (2016-2021)
7.2.2 Europe Blood Pressure Disorders Drug Market Size by Type (2022-2027)
7.2.3 Europe Blood Pressure Disorders Drug Market Size by Type (2016-2027)
7.3 Europe Blood Pressure Disorders Drug Market Size by Application
7.3.1 Europe Blood Pressure Disorders Drug Market Size by Application (2016-2021)
7.3.2 Europe Blood Pressure Disorders Drug Market Size by Application (2022-2027)
7.3.3 Europe Blood Pressure Disorders Drug Market Size by Application (2016-2027)
7.4 Europe Blood Pressure Disorders Drug Market Size by Country
7.4.1 Europe Blood Pressure Disorders Drug Market Size by Country (2016-2021)
7.4.2 Europe Blood Pressure Disorders Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Blood Pressure Disorders Drug Market Size (2016-2027)
8.2 Asia-Pacific Blood Pressure Disorders Drug Market Size by Type
8.2.1 Asia-Pacific Blood Pressure Disorders Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Blood Pressure Disorders Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Blood Pressure Disorders Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Blood Pressure Disorders Drug Market Size by Application
8.3.1 Asia-Pacific Blood Pressure Disorders Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Blood Pressure Disorders Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Blood Pressure Disorders Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Blood Pressure Disorders Drug Market Size by Region
8.4.1 Asia-Pacific Blood Pressure Disorders Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Blood Pressure Disorders Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Blood Pressure Disorders Drug Market Size (2016-2027)
9.2 Latin America Blood Pressure Disorders Drug Market Size by Type
9.2.1 Latin America Blood Pressure Disorders Drug Market Size by Type (2016-2021)
9.2.2 Latin America Blood Pressure Disorders Drug Market Size by Type (2022-2027)
9.2.3 Latin America Blood Pressure Disorders Drug Market Size by Type (2016-2027)
9.3 Latin America Blood Pressure Disorders Drug Market Size by Application
9.3.1 Latin America Blood Pressure Disorders Drug Market Size by Application (2016-2021)
9.3.2 Latin America Blood Pressure Disorders Drug Market Size by Application (2022-2027)
9.3.3 Latin America Blood Pressure Disorders Drug Market Size by Application (2016-2027)
9.4 Latin America Blood Pressure Disorders Drug Market Size by Country
9.4.1 Latin America Blood Pressure Disorders Drug Market Size by Country (2016-2021)
9.4.2 Latin America Blood Pressure Disorders Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Pressure Disorders Drug Market Size (2016-2027)
10.2 Middle East & Africa Blood Pressure Disorders Drug Market Size by Type
10.2.1 Middle East & Africa Blood Pressure Disorders Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Blood Pressure Disorders Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Blood Pressure Disorders Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Blood Pressure Disorders Drug Market Size by Application
10.3.1 Middle East & Africa Blood Pressure Disorders Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Blood Pressure Disorders Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Blood Pressure Disorders Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Blood Pressure Disorders Drug Market Size by Country
10.4.1 Middle East & Africa Blood Pressure Disorders Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Blood Pressure Disorders Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 A1M Pharma AB
11.1.1 A1M Pharma AB Company Details
11.1.2 A1M Pharma AB Business Overview
11.1.3 A1M Pharma AB Blood Pressure Disorders Drug Introduction
11.1.4 A1M Pharma AB Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.1.5 A1M Pharma AB Recent Development
11.2 Acceleron Pharma Inc
11.2.1 Acceleron Pharma Inc Company Details
11.2.2 Acceleron Pharma Inc Business Overview
11.2.3 Acceleron Pharma Inc Blood Pressure Disorders Drug Introduction
11.2.4 Acceleron Pharma Inc Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.2.5 Acceleron Pharma Inc Recent Development
11.3 Ache Laboratorios Farmaceuticos SA
11.3.1 Ache Laboratorios Farmaceuticos SA Company Details
11.3.2 Ache Laboratorios Farmaceuticos SA Business Overview
11.3.3 Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Introduction
11.3.4 Ache Laboratorios Farmaceuticos SA Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.3.5 Ache Laboratorios Farmaceuticos SA Recent Development
11.4 Actelion Pharmaceuticals Ltd
11.4.1 Actelion Pharmaceuticals Ltd Company Details
11.4.2 Actelion Pharmaceuticals Ltd Business Overview
11.4.3 Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Introduction
11.4.4 Actelion Pharmaceuticals Ltd Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.4.5 Actelion Pharmaceuticals Ltd Recent Development
11.5 Aerogen Ltd
11.5.1 Aerogen Ltd Company Details
11.5.2 Aerogen Ltd Business Overview
11.5.3 Aerogen Ltd Blood Pressure Disorders Drug Introduction
11.5.4 Aerogen Ltd Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.5.5 Aerogen Ltd Recent Development
11.6 Anavex Life Sciences Corp
11.6.1 Anavex Life Sciences Corp Company Details
11.6.2 Anavex Life Sciences Corp Business Overview
11.6.3 Anavex Life Sciences Corp Blood Pressure Disorders Drug Introduction
11.6.4 Anavex Life Sciences Corp Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.6.5 Anavex Life Sciences Corp Recent Development
11.7 AnGes Inc
11.7.1 AnGes Inc Company Details
11.7.2 AnGes Inc Business Overview
11.7.3 AnGes Inc Blood Pressure Disorders Drug Introduction
11.7.4 AnGes Inc Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.7.5 AnGes Inc Recent Development
11.8 Arena Pharmaceuticals Inc
11.8.1 Arena Pharmaceuticals Inc Company Details
11.8.2 Arena Pharmaceuticals Inc Business Overview
11.8.3 Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Introduction
11.8.4 Arena Pharmaceuticals Inc Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.8.5 Arena Pharmaceuticals Inc Recent Development
11.9 Ascendia Pharmaceuticals LLC
11.9.1 Ascendia Pharmaceuticals LLC Company Details
11.9.2 Ascendia Pharmaceuticals LLC Business Overview
11.9.3 Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Introduction
11.9.4 Ascendia Pharmaceuticals LLC Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.9.5 Ascendia Pharmaceuticals LLC Recent Development
11.10 Ascendis Pharma A/S
11.10.1 Ascendis Pharma A/S Company Details
11.10.2 Ascendis Pharma A/S Business Overview
11.10.3 Ascendis Pharma A/S Blood Pressure Disorders Drug Introduction
11.10.4 Ascendis Pharma A/S Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.10.5 Ascendis Pharma A/S Recent Development
11.11 AVEO Pharmaceuticals Inc
11.11.1 AVEO Pharmaceuticals Inc Company Details
11.11.2 AVEO Pharmaceuticals Inc Business Overview
11.11.3 AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Introduction
11.11.4 AVEO Pharmaceuticals Inc Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.11.5 AVEO Pharmaceuticals Inc Recent Development
11.12 Bayer AG
11.12.1 Bayer AG Company Details
11.12.2 Bayer AG Business Overview
11.12.3 Bayer AG Blood Pressure Disorders Drug Introduction
11.12.4 Bayer AG Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.12.5 Bayer AG Recent Development
11.13 Bial – Portela & Ca SA
11.13.1 Bial – Portela & Ca SA Company Details
11.13.2 Bial – Portela & Ca SA Business Overview
11.13.3 Bial – Portela & Ca SA Blood Pressure Disorders Drug Introduction
11.13.4 Bial – Portela & Ca SA Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.13.5 Bial – Portela & Ca SA Recent Development
11.14 Bioblue Technologies Inc
11.14.1 Bioblue Technologies Inc Company Details
11.14.2 Bioblue Technologies Inc Business Overview
11.14.3 Bioblue Technologies Inc Blood Pressure Disorders Drug Introduction
11.14.4 Bioblue Technologies Inc Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.14.5 Bioblue Technologies Inc Recent Development
11.15 Biogen Inc
11.15.1 Biogen Inc Company Details
11.15.2 Biogen Inc Business Overview
11.15.3 Biogen Inc Blood Pressure Disorders Drug Introduction
11.15.4 Biogen Inc Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.15.5 Biogen Inc Recent Development
11.16 Biolab Farmaceutica Ltda
11.16.1 Biolab Farmaceutica Ltda Company Details
11.16.2 Biolab Farmaceutica Ltda Business Overview
11.16.3 Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Introduction
11.16.4 Biolab Farmaceutica Ltda Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.16.5 Biolab Farmaceutica Ltda Recent Development
11.17 BioRestorative Therapies Inc
11.17.1 BioRestorative Therapies Inc Company Details
11.17.2 BioRestorative Therapies Inc Business Overview
11.17.3 BioRestorative Therapies Inc Blood Pressure Disorders Drug Introduction
11.17.4 BioRestorative Therapies Inc Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.17.5 BioRestorative Therapies Inc Recent Development
11.18 Boryung Pharmaceutical Co Ltd
11.18.1 Boryung Pharmaceutical Co Ltd Company Details
11.18.2 Boryung Pharmaceutical Co Ltd Business Overview
11.18.3 Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Introduction
11.18.4 Boryung Pharmaceutical Co Ltd Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.18.5 Boryung Pharmaceutical Co Ltd Recent Development
11.18 Bristol-Myers Squibb Co
11.25.1 Bristol-Myers Squibb Co Company Details
11.25.2 Bristol-Myers Squibb Co Business Overview
11.25.3 Bristol-Myers Squibb Co Blood Pressure Disorders Drug Introduction
11.25.4 Bristol-Myers Squibb Co Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.25.5 Bristol-Myers Squibb Co Recent Development
11.20 Camurus AB
11.20.1 Camurus AB Company Details
11.20.2 Camurus AB Business Overview
11.20.3 Camurus AB Blood Pressure Disorders Drug Introduction
11.20.4 Camurus AB Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.20.5 Camurus AB Recent Development
11.21 Capricor Therapeutics Inc
11.21.1 Capricor Therapeutics Inc Company Details
11.21.2 Capricor Therapeutics Inc Business Overview
11.21.3 Capricor Therapeutics Inc Blood Pressure Disorders Drug Introduction
11.21.4 Capricor Therapeutics Inc Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.21.5 Capricor Therapeutics Inc Recent Development
11.22 Celsion Corp
11.22.1 Celsion Corp Company Details
11.22.2 Celsion Corp Business Overview
11.22.3 Celsion Corp Blood Pressure Disorders Drug Introduction
11.22.4 Celsion Corp Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.22.5 Celsion Corp Recent Development
11.23 Celtaxsys Inc
11.23.1 Celtaxsys Inc Company Details
11.23.2 Celtaxsys Inc Business Overview
11.23.3 Celtaxsys Inc Blood Pressure Disorders Drug Introduction
11.23.4 Celtaxsys Inc Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.23.5 Celtaxsys Inc Recent Development
11.24 Chiesi Farmaceutici SpA
11.24.1 Chiesi Farmaceutici SpA Company Details
11.24.2 Chiesi Farmaceutici SpA Business Overview
11.24.3 Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Introduction
11.24.4 Chiesi Farmaceutici SpA Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.24.5 Chiesi Farmaceutici SpA Recent Development
11.25 Chong Kun Dang Pharmaceutical Corp
11.25.1 Chong Kun Dang Pharmaceutical Corp Company Details
11.25.2 Chong Kun Dang Pharmaceutical Corp Business Overview
11.25.3 Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Introduction
11.25.4 Chong Kun Dang Pharmaceutical Corp Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.25.5 Chong Kun Dang Pharmaceutical Corp Recent Development
11.26 Chugai Pharmaceutical Co Ltd
11.26.1 Chugai Pharmaceutical Co Ltd Company Details
11.26.2 Chugai Pharmaceutical Co Ltd Business Overview
11.26.3 Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Introduction
11.26.4 Chugai Pharmaceutical Co Ltd Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.26.5 Chugai Pharmaceutical Co Ltd Recent Development
11.27 CJ HealthCare Corp
11.27.1 CJ HealthCare Corp Company Details
11.27.2 CJ HealthCare Corp Business Overview
11.27.3 CJ HealthCare Corp Blood Pressure Disorders Drug Introduction
11.27.4 CJ HealthCare Corp Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.27.5 CJ HealthCare Corp Recent Development
11.28 Complexa Inc
11.28.1 Complexa Inc Company Details
11.28.2 Complexa Inc Business Overview
11.28.3 Complexa Inc Blood Pressure Disorders Drug Introduction
11.28.4 Complexa Inc Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.28.5 Complexa Inc Recent Development
11.29 Corion Biotech Srl
11.29.1 Corion Biotech Srl Company Details
11.29.2 Corion Biotech Srl Business Overview
11.29.3 Corion Biotech Srl Blood Pressure Disorders Drug Introduction
11.29.4 Corion Biotech Srl Revenue in Blood Pressure Disorders Drug Business (2016-2021)
11.29.5 Corion Biotech Srl Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Blood Pressure Disorders Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Diuretics
Table 3. Key Players of Angiotensin Converting Enzyme (ACE) Inhibitors
Table 4. Key Players of Angiotensin Receptor Blockers (ARBs)
Table 5. Key Players of Others
Table 6. Global Blood Pressure Disorders Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Blood Pressure Disorders Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Blood Pressure Disorders Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Blood Pressure Disorders Drug Market Share by Regions (2016-2021)
Table 10. Global Blood Pressure Disorders Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Blood Pressure Disorders Drug Market Share by Regions (2022-2027)
Table 12. Blood Pressure Disorders Drug Market Trends
Table 13. Blood Pressure Disorders Drug Market Drivers
Table 14. Blood Pressure Disorders Drug Market Challenges
Table 15. Blood Pressure Disorders Drug Market Restraints
Table 16. Global Blood Pressure Disorders Drug Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Blood Pressure Disorders Drug Market Share by Players (2016-2021)
Table 18. Global Top Blood Pressure Disorders Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood Pressure Disorders Drug as of 2020)
Table 19. Ranking of Global Top Blood Pressure Disorders Drug Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Blood Pressure Disorders Drug Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Blood Pressure Disorders Drug Product Solution and Service
Table 23. Date of Enter into Blood Pressure Disorders Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Blood Pressure Disorders Drug Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Blood Pressure Disorders Drug Revenue Market Share by Type (2016-2021)
Table 27. Global Blood Pressure Disorders Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Blood Pressure Disorders Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Blood Pressure Disorders Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Blood Pressure Disorders Drug Revenue Market Share by Application (2016-2021)
Table 31. Global Blood Pressure Disorders Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Blood Pressure Disorders Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Blood Pressure Disorders Drug Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Blood Pressure Disorders Drug Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Blood Pressure Disorders Drug Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Blood Pressure Disorders Drug Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Blood Pressure Disorders Drug Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Blood Pressure Disorders Drug Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Blood Pressure Disorders Drug Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Blood Pressure Disorders Drug Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Blood Pressure Disorders Drug Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Blood Pressure Disorders Drug Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Blood Pressure Disorders Drug Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Blood Pressure Disorders Drug Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Blood Pressure Disorders Drug Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Blood Pressure Disorders Drug Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Blood Pressure Disorders Drug Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Blood Pressure Disorders Drug Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Blood Pressure Disorders Drug Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Blood Pressure Disorders Drug Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Blood Pressure Disorders Drug Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Blood Pressure Disorders Drug Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Blood Pressure Disorders Drug Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Blood Pressure Disorders Drug Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Blood Pressure Disorders Drug Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Blood Pressure Disorders Drug Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Blood Pressure Disorders Drug Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Blood Pressure Disorders Drug Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Blood Pressure Disorders Drug Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Blood Pressure Disorders Drug Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Blood Pressure Disorders Drug Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Blood Pressure Disorders Drug Market Size by Country (2022-2027) & (US$ Million)
Table 63. A1M Pharma AB Company Details
Table 64. A1M Pharma AB Business Overview
Table 65. A1M Pharma AB Blood Pressure Disorders Drug Product
Table 66. A1M Pharma AB Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 67. A1M Pharma AB Recent Development
Table 68. Acceleron Pharma Inc Company Details
Table 69. Acceleron Pharma Inc Business Overview
Table 70. Acceleron Pharma Inc Blood Pressure Disorders Drug Product
Table 71. Acceleron Pharma Inc Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 72. Acceleron Pharma Inc Recent Development
Table 73. Ache Laboratorios Farmaceuticos SA Company Details
Table 74. Ache Laboratorios Farmaceuticos SA Business Overview
Table 75. Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Product
Table 76. Ache Laboratorios Farmaceuticos SA Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 77. Ache Laboratorios Farmaceuticos SA Recent Development
Table 78. Actelion Pharmaceuticals Ltd Company Details
Table 79. Actelion Pharmaceuticals Ltd Business Overview
Table 80. Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Product
Table 81. Actelion Pharmaceuticals Ltd Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 82. Actelion Pharmaceuticals Ltd Recent Development
Table 83. Aerogen Ltd Company Details
Table 84. Aerogen Ltd Business Overview
Table 85. Aerogen Ltd Blood Pressure Disorders Drug Product
Table 86. Aerogen Ltd Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 87. Aerogen Ltd Recent Development
Table 88. Anavex Life Sciences Corp Company Details
Table 89. Anavex Life Sciences Corp Business Overview
Table 90. Anavex Life Sciences Corp Blood Pressure Disorders Drug Product
Table 91. Anavex Life Sciences Corp Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 92. Anavex Life Sciences Corp Recent Development
Table 93. AnGes Inc Company Details
Table 94. AnGes Inc Business Overview
Table 95. AnGes Inc Blood Pressure Disorders Drug Product
Table 96. AnGes Inc Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 97. AnGes Inc Recent Development
Table 98. Arena Pharmaceuticals Inc Company Details
Table 99. Arena Pharmaceuticals Inc Business Overview
Table 100. Arena Pharmaceuticals Inc Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 101. Arena Pharmaceuticals Inc Recent Development
Table 102. Ascendia Pharmaceuticals LLC Company Details
Table 103. Ascendia Pharmaceuticals LLC Business Overview
Table 104. Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Product
Table 105. Ascendia Pharmaceuticals LLC Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 106. Ascendia Pharmaceuticals LLC Recent Development
Table 107. Ascendis Pharma A/S Company Details
Table 108. Ascendis Pharma A/S Business Overview
Table 109. Ascendis Pharma A/S Blood Pressure Disorders Drug Product
Table 110. Ascendis Pharma A/S Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 111. Ascendis Pharma A/S Recent Development
Table 112. AVEO Pharmaceuticals Inc Company Details
Table 113. AVEO Pharmaceuticals Inc Business Overview
Table 114. AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Product
Table 115. AVEO Pharmaceuticals Inc Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 116. AVEO Pharmaceuticals Inc Recent Development
Table 117. Bayer AG Company Details
Table 118. Bayer AG Business Overview
Table 119. Bayer AG Blood Pressure Disorders Drug Product
Table 120. Bayer AG Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 121. Bayer AG Recent Development
Table 122. Bial - Portela & Ca SA Company Details
Table 123. Bial - Portela & Ca SA Business Overview
Table 124. Bial - Portela & Ca SA Blood Pressure Disorders Drug Product
Table 125. Bial - Portela & Ca SA Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 126. Bial - Portela & Ca SA Recent Development
Table 127. Bioblue Technologies Inc Company Details
Table 128. Bioblue Technologies Inc Business Overview
Table 129. Bioblue Technologies Inc Blood Pressure Disorders Drug Product
Table 130. Bioblue Technologies Inc Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 131. Bioblue Technologies Inc Recent Development
Table 132. Biogen Inc Company Details
Table 133. Biogen Inc Business Overview
Table 134. Biogen Inc Blood Pressure Disorders Drug Product
Table 135. Biogen Inc Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 136. Biogen Inc Recent Development
Table 137. Biolab Farmaceutica Ltda Company Details
Table 138. Biolab Farmaceutica Ltda Business Overview
Table 139. Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Product
Table 140. Biolab Farmaceutica Ltda Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 141. Biolab Farmaceutica Ltda Recent Development
Table 142. BioRestorative Therapies Inc Company Details
Table 143. BioRestorative Therapies Inc Business Overview
Table 144. BioRestorative Therapies Inc Blood Pressure Disorders Drug Product
Table 145. BioRestorative Therapies Inc Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 146. BioRestorative Therapies Inc Recent Development
Table 147. Boryung Pharmaceutical Co Ltd Company Details
Table 148. Boryung Pharmaceutical Co Ltd Business Overview
Table 149. Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Product
Table 150. Boryung Pharmaceutical Co Ltd Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 151. Boryung Pharmaceutical Co Ltd Recent Development
Table 152. Bristol-Myers Squibb Co Company Details
Table 153. Bristol-Myers Squibb Co Business Overview
Table 154. Bristol-Myers Squibb Co Blood Pressure Disorders Drug Product
Table 155. Bristol-Myers Squibb Co Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 156. Bristol-Myers Squibb Co Recent Development
Table 157. Camurus AB Company Details
Table 158. Camurus AB Business Overview
Table 159. Camurus AB Blood Pressure Disorders Drug Product
Table 160. Camurus AB Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 161. Camurus AB Recent Development
Table 162. Capricor Therapeutics Inc Company Details
Table 163. Capricor Therapeutics Inc Business Overview
Table 164. Capricor Therapeutics Inc Blood Pressure Disorders Drug Product
Table 165. Capricor Therapeutics Inc Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 166. Capricor Therapeutics Inc Recent Development
Table 167. Celsion Corp Company Details
Table 168. Celsion Corp Business Overview
Table 169. Celsion Corp Blood Pressure Disorders Drug Product
Table 170. Celsion Corp Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 171. Celsion Corp Recent Development
Table 172. Celtaxsys Inc Company Details
Table 173. Celtaxsys Inc Business Overview
Table 174. Celtaxsys Inc Blood Pressure Disorders Drug Product
Table 175. Celtaxsys Inc Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 176. Celtaxsys Inc Recent Development
Table 177. Chiesi Farmaceutici SpA Company Details
Table 178. Chiesi Farmaceutici SpA Business Overview
Table 179. Chiesi Farmaceutici SpA Blood Pressure Disorders DrugProduct
Table 180. Chiesi Farmaceutici SpA Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 181. Chiesi Farmaceutici SpA Recent Development
Table 182. Chong Kun Dang Pharmaceutical Corp Company Details
Table 183. Chong Kun Dang Pharmaceutical Corp Business Overview
Table 184. Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Product
Table 185. Chong Kun Dang Pharmaceutical Corp Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 186. Chong Kun Dang Pharmaceutical Corp Recent Development
Table 187. Chugai Pharmaceutical Co Ltd Company Details
Table 188. Chugai Pharmaceutical Co Ltd Business Overview
Table 189. Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Product
Table 190. Chugai Pharmaceutical Co Ltd Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 191. Chugai Pharmaceutical Co Ltd Recent Development
Table 192. CJ HealthCare Corp Company Details
Table 193. CJ HealthCare Corp Business Overview
Table 194. CJ HealthCare Corp Blood Pressure Disorders Drug Product
Table 195. CJ HealthCare Corp Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 196. CJ HealthCare Corp Recent Development
Table 197. Complexa Inc Company Details
Table 198. Complexa Inc Business Overview
Table 199. Complexa Inc Blood Pressure Disorders Drug Product
Table 200. Complexa Inc Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 201. Complexa Inc Recent Development
Table 202. Corion Biotech Srl Company Details
Table 203. Corion Biotech Srl Business Overview
Table 204. Corion Biotech Srl Blood Pressure Disorders Drug Product
Table 205. Corion Biotech Srl Revenue in Blood Pressure Disorders Drug Business (2016-2021) & (US$ Million)
Table 206. Corion Biotech Srl Recent Development
Table 207. Research Programs/Design for This Report
Table 208. Key Data Information from Secondary Sources
Table 209. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Blood Pressure Disorders Drug Market Share by Type: 2020 VS 2027
Figure 2. Diuretics Features
Figure 3. Angiotensin Converting Enzyme (ACE) Inhibitors Features
Figure 4. Angiotensin Receptor Blockers (ARBs) Features
Figure 5. Others Features
Figure 6. Global Blood Pressure Disorders Drug Market Share by Application: 2020 VS 2027
Figure 7. Hypertension Case Studies
Figure 8. Hypotension Case Studies
Figure 9. Pulmonary Hypertension Case Studies
Figure 10. Blood Pressure Disorders Drug Report Years Considered
Figure 11. Global Blood Pressure Disorders Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Blood Pressure Disorders Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Blood Pressure Disorders Drug Market Share by Regions: 2020 VS 2027
Figure 14. Global Blood Pressure Disorders Drug Market Share by Regions (2022-2027)
Figure 15. Global Blood Pressure Disorders Drug Market Share by Players in 2020
Figure 16. Global Top Blood Pressure Disorders Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood Pressure Disorders Drug as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Blood Pressure Disorders Drug Revenue in 2020
Figure 18. Global Blood Pressure Disorders Drug Revenue Market Share by Type (2016-2021)
Figure 19. Global Blood Pressure Disorders Drug Revenue Market Share by Type (2022-2027)
Figure 20. North America Blood Pressure Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Blood Pressure Disorders Drug Market Share by Type (2016-2027)
Figure 22. North America Blood Pressure Disorders Drug Market Share by Application (2016-2027)
Figure 23. North America Blood Pressure Disorders Drug Market Share by Country (2016-2027)
Figure 24. United States Blood Pressure Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Blood Pressure Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Blood Pressure Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Blood Pressure Disorders Drug Market Share by Type (2016-2027)
Figure 28. Europe Blood Pressure Disorders Drug Market Share by Application (2016-2027)
Figure 29. Europe Blood Pressure Disorders Drug Market Share by Country (2016-2027)
Figure 30. Germany Blood Pressure Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Blood Pressure Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Blood Pressure Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Blood Pressure Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Blood Pressure Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Blood Pressure Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Blood Pressure Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Blood Pressure Disorders Drug Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Blood Pressure Disorders Drug Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Blood Pressure Disorders Drug Market Share by Region (2016-2027)
Figure 40. China Blood Pressure Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Blood Pressure Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Blood Pressure Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Blood Pressure Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Blood Pressure Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Blood Pressure Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Blood Pressure Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Blood Pressure Disorders Drug Market Share by Type (2016-2027)
Figure 48. Latin America Blood Pressure Disorders Drug Market Share by Application (2016-2027)
Figure 49. Latin America Blood Pressure Disorders Drug Market Share by Country (2016-2027)
Figure 50. Mexico Blood Pressure Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Blood Pressure Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Blood Pressure Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Blood Pressure Disorders Drug Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Blood Pressure Disorders Drug Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Blood Pressure Disorders Drug Market Share by Country (2016-2027)
Figure 56. Turkey Blood Pressure Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Blood Pressure Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Blood Pressure Disorders Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. A1M Pharma AB Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 60. Acceleron Pharma Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 61. Ache Laboratorios Farmaceuticos SA Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 62. Actelion Pharmaceuticals Ltd Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 63. Aerogen Ltd Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 64. Anavex Life Sciences Corp Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 65. AnGes Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 66. Arena Pharmaceuticals Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 67. Ascendia Pharmaceuticals LLC Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 68. Ascendis Pharma A/S Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 69. AVEO Pharmaceuticals Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 70. Bayer AG Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 71. Bial - Portela & Ca SA Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 72. Bioblue Technologies Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 73. Biogen Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 74. Biolab Farmaceutica Ltda Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 75. BioRestorative Therapies Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 76. Boryung Pharmaceutical Co Ltd Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 77. Bristol-Myers Squibb Co Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 78. Camurus AB Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 79. Capricor Therapeutics Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 80. Celsion Corp Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 81. Celtaxsys Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 82. Chiesi Farmaceutici SpA Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 83. Chong Kun Dang Pharmaceutical Corp Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 84. Chugai Pharmaceutical Co Ltd Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 85. CJ HealthCare Corp Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 86. Complexa Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 87. Corion Biotech Srl Revenue Growth Rate in Blood Pressure Disorders Drug Business (2016-2021)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
世界のアンジオテンシン変換酵素阻害剤市場規模・現状・予測（2021年-2027年） Angiotensin converting enzyme inhibitors (ACE inhibitors) are medications that slow (inhibit) the activity of the enzyme ACE, which decreases the production of angiotensin II. Market Analysis and Insights: Global Angiotensin Converting Enzyme Inhibitors Market The global Angiotensin Converting Enzym…- 高血圧薬のグローバル市場調査 2019年 The global High Blood Pressure Drugs (Hypertension) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on High Blood Pressure Drugs (Hypertension) volume and value at global level, regional level and comp…
- 世界のリウマチ疾患治療薬市場規模・現状・予測（2021年-2027年） Treatment of drugs for regulating rheumatic diseases Rheumatic diseases are a series of diseases characterized by chronic pain. Some of the most common diseases are osteoarthritis (OA) and rheumatoid arthritis (RA), and most rheumatic diseases use basically universal pain control drugs. Treatment is…
- 世界の高血圧＆心不全治療薬市場規模・現状・予測（2021年-2027年） Hypertension and Heart Failure Drugs such as β-blockers, angiotensin-converting enzyme inhibitiors, angiotensin receptor blockers, aldosterone receptor blockers, hydralazine and nitrates, which have shown mortality benefit in CHF and exert antihypertensive effects, are used as first-line agents to c…
- 世界の不安障害＆うつ病治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anxiety Disorders And Depression Therapeutic Drug Market The global Anxiety Disorders And Depression Therapeutic Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard …